SR 2020 Commitment Description 4. Building resilience at home and overseas Situation Centre and Cabinet Office Briefing Rooms (CO) • £9.3m to provide continued support to the COBR crisis suite and establish a Situation Centre which will provide live data, analysis and insights to decision-makers on what is happening in the UK and around the world, strengthening our ability to identify, understand and respond to national security issues and crises. Climate change and biodiversity • £12bn investment to support a green industrial revolution including innovative clean energy technologies, low hydrogen carbon production, carbon capture and storage, offshore wind and nuclear power. Provides funding for the Prime Minister’s ten-point plan, which has set out the Government’s vision to tackle climate change while simultaneously supporting hundreds of thousands of jobs across the UK. • The Prime Minister committed in 2019 to double the UK’s public ICF to at least £11.6bn between 2021 and 2025. ICF will help developing countries limit their greenhouse gas emissions and adapt to the impacts of climate change. • £5.2bn in the next six-year flood and coastal defence programme, and £200m on innovative resilience measures over the same period. This is to better protect homes and communities across England from flooding and to ensure they are better prepared for when it does happen. • This accompanies allocations for the Nature for Climate Fund (£92m), Green Recovery Challenge Fund (£80m) and an additional £7m for biodiversity conservation in the Overseas Territories. Health resilience (DHSC, BEIS, MHCLG, FCDO) • £6bn to develop and procure COVID-19 vaccines, as well as over £5.4bn to help local authorities respond to COVID-19 in 2020-21. • £1.3bn to DHSC for R&D to continue the world-leading work of the National Institute for Health Research and Genomics England and their research into better patient outcomes, including on COVID-19 research, as well as supporting the wider UK life sciences sector. • £548m available through the COVAX Advance Market Commitment to support developing countries’ access to COVID-19 vaccines. 104 Integrated Review

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents